Results 161 to 170 of about 7,313 (199)

Spravato (Esketamine)

Asian Journal of Nursing Education and Research, 2023
Depression is more than feeling a little sad or "blue" for a few days. Antidepressant medications are used in the treatment of clinical depression, usually alongside other forms of therapy such as psychological or behavioral therapy. Spravato is a medicine used to treat adults with major depression that is resistant to treatment.
Nirosha V., Gayathri V.
openaire   +1 more source

Esketamine

Reactions Weekly
  +8 more sources

Esketamine for treatment resistant depression

BMJ, 2019
Introduction: Treatment Resistant Depression (TRD) is a common and burdensome condition with poor outcomes and few treatment options. Esketamine is the S-enantiomer of ketamine and has recently been FDA approved in the United States for treating depression that has failed to respond to trials of two or more antidepressants.
Sameer, Jauhar, Paul, Morrison
openaire   +4 more sources

NICE reconsiders esketamine for depression

BMJ, 2020
The National Institute for Health and Care Excellence (NICE) has launched a second consultation on the use of esketamine for treatment resistant depression, after feedback showed that it could benefit some patients. Guidance published in January 2020 did not recommend esketamine for treatment resistant depression and said that the drug should not be ...
openaire   +2 more sources

Esketamine

Reactions Weekly, 2022
  +4 more sources

Esketamine for treatment-resistant depression

Drug and Therapeutics Bulletin, 2020
Generic name: Esketamine hydrochloride Brand name: Spravato Formulation: 28mg in 0.2ml nasal spray solution Market Authorisation holder: Janssen-Cilag International NV Indication: Treatment resistant
openaire   +2 more sources

Esketamine: Less Drowsiness, More Analgesia

Anesthesia & Analgesia
Racemic ketamine is a 1:1 mixture of 2 enantiomers that turn light in opposite direction: Dextrorotatory esketamine is approximately 4 times more affine for the N-methyl-D-aspartate (NMDA) receptor than levorotatory arketamine, which may explain why esketamine is about twice as potent as an analgesic and anesthetic as the racemate.
Georges, Mion, Sabine, Himmelseher
openaire   +2 more sources

Ketamin und Esketamin

Nervenheilkunde
ZUSAMMENFASSUNGKetamin blickt bereits auf eine längere Geschichte der Anwendung in der Psychiatrie zurück. Insbesondere ist es in den letzten 2 Dekaden zur Behandlung von therapieresistenten Depressionen erforscht und eingesetzt worden und ist mit dem Enantiomer Esketamin in Deutschland für diese Indikation zugelassen.
Cornelius Schüle, Gabi Koller, Uwe Herwig   +2 more
openaire   +1 more source